Login

Healthcare

00:00:00
Faron Pharmaceuticals initiates second phase of BEXMAB study -Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
Faron Pharmaceuticals kicks off second half with FDA announcement -Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
Futura Medical continues global expansion with Latin America announcement - James Barder, Chief Executive, Futura Medical
00:00:00
Futura Medical "on track for a profit in 2025" after strong first half - James Barder, Chief Executive, Futura Medical
00:00:00
CEO Paul McDonald talks of the huge pipeline going forward - Paul McDonald Chief Executive Officer, IDT Australia Ltd
00:00:00
Immunicum | CEO interview, Erik Manting, CEO, Immunicum
00:00:00
ImmuPharma "absolutely delighted" to push on with new clinical trial -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:00:00
ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:00:00
Update from Genesis HealthCare System CEO & President Matthew J. Perry
00:00:00
Highlights Genetic Technologies (NASDAQ: GENE) -Simon Morriss, CEO, Genetic Technologies Ltd
00:00:00
Genetic Technologies building pathway to profitability - Simon Morriss, CEO, Genetic Technologies Ltd
00:00:00
Simon Morriss, CEO, Genetic Technologies Ltd
00:00:00
Genetic Technologies: Decoding the Genome and Unlocking its Value for Human Health - Simon Morriss, CEO, Genetic Technologies Ltd
00:00:00
Genetic Technologies embraces global vision for genomic-integrated healthcare -Simon Morriss, CEO, Genetic Technologies Ltd
00:00:00
GeNeuro SA (ENXTPA:GNRO) Executive Presentation -Jesús Martin-Garcia, Chief Executive Officer, Geneuro
00:00:00
GeNeuro homes in on ancestral viral genes to treat autoimmune diseases - Jesús Martin-Garcia, Chief Executive Officer, Geneuro

© 2017 - Townhall + Tv